Stock price when the opinion was issued
It reported a beat this morning, but they always set a really low bar in earnings, and the long-time CEO announced his retirement. The CEO guided it to great heights, but recent disastrous declines in earnings. The pandemic hurt their Chinese sales and that has never recovered; also, airport sales haven't recovered. Since the start of 2022, Estee Lauder has sank 75% while ELF has soared 382%. Lauder maintained high prices to protect their margins, but that may be working anymore.
Fundamental driver of business very strong - vanity products. Long history of well established brands. China growth has slowed, but overall is optimistic on company. Not founder run, but founder still owns large chunk of business. Is ~1% position in portfolio. Will keep buying on share price weakness.
He'd own it for the next couple of months, but questions the next couple of years. Clinique is strong, but has lost some of its brand "heat". Weaker topline. Revenue coming down at the same time as costs are inflating. Tactically bullish if you believe the spurt in China is real, but tends to get more competitive over the long term, and that will come home to roost for EL over a 5-year horizon.
See his Top Picks for a more durable idea.
There is still lots of risk here but we think the potential is also looking good from current levels. The company is still quite levered, but it generates good cash flow. EPS will fall this year but better things are expected in 2026. With its slowdown, the company has some serious cost-cutting efforts ongoing, and if these work there is good leverage to earnings. We would not want a lot, and it is for recovery-style patient investors only, but we think it will ultimately recover well enough.
Unlock Premium - Try 5i Free